论文部分内容阅读
溶栓治疗是近年来治疗急性心肌梗塞（AMI）的重大进展。我们从1994年起采用国产尿激酶（天普洛欣）对13例AMI病人行静脉溶栓治疗，现总结如下。1资料和方法1.1一般资料：（1）凡符合溶栓治疗适应证及无禁忌证的AMI住院病人，均接受天普洛欣静脉溶栓治疗。其中男11例，女2例。年
Thrombolytic therapy is a major advance in the treatment of acute myocardial infarction (AMI) in recent years. We started with intravenous thrombolysis in 13 patients with AMI using domestic urokinase (dayopromycin) since 1994, are summarized as follows. 1 Materials and Methods 1.1 General Information: (1) All patients with AMI who meet the indications for thrombolytic therapy and no contraindications received intravenous thrombolysis. Including 11 males and 2 females. year